- Home
- CON vs SRRK Comparison
CON vs SRRK Comparison
Compare CON & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CON
- SRRK
- Stock Information
- Founded
- CON 1979
- SRRK 2012
- Country
- CON United States
- SRRK United States
- Employees
- CON N/A
- SRRK N/A
- Industry
- CON
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CON
- SRRK Health Care
- Exchange
- CON NYSE
- SRRK Nasdaq
- Market Cap
- CON 2.8B
- SRRK 3.2B
- IPO Year
- CON 2024
- SRRK 2018
- Fundamental
- Price
- CON $20.75
- SRRK $34.04
- Analyst Decision
- CON Strong Buy
- SRRK Strong Buy
- Analyst Count
- CON 7
- SRRK 6
- Target Price
- CON $29.00
- SRRK $42.17
- AVG Volume (30 Days)
- CON 524.0K
- SRRK 1.3M
- Earning Date
- CON 07-31-2025
- SRRK 08-07-2025
- Dividend Yield
- CON 0.90%
- SRRK N/A
- EPS Growth
- CON N/A
- SRRK N/A
- EPS
- CON 1.30
- SRRK N/A
- Revenue
- CON $1,933,346,000.00
- SRRK N/A
- Revenue This Year
- CON $13.09
- SRRK N/A
- Revenue Next Year
- CON $7.35
- SRRK $502.60
- P/E Ratio
- CON $15.94
- SRRK N/A
- Revenue Growth
- CON 4.54
- SRRK N/A
- 52 Week Low
- CON $18.89
- SRRK $6.76
- 52 Week High
- CON $24.81
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- CON N/A
- SRRK 55.54
- Support Level
- CON N/A
- SRRK $30.97
- Resistance Level
- CON N/A
- SRRK $37.00
- Average True Range (ATR)
- CON 0.00
- SRRK 2.05
- MACD
- CON 0.00
- SRRK 0.23
- Stochastic Oscillator
- CON 0.00
- SRRK 65.40
About CON CONCENTRA GROUP HOLDINGS PARENT INC
Concentra Group Holdings Parent Inc is a provider of occupational health services in the United States. The business is organized into three operating segments: occupational health centers, onsite health clinics, and other businesses.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.